Approval · Notice of Compliance 3372 · 2003
SYNPHASIC 21 TABLETS: Notice of Compliance 3372
Issued October 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3372
- Date
- October 14, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNPHASIC 21 TABLETS | 02187108 | Marketed |
| SYNPHASIC 28 TABLETS | 02187116 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.035 MG per TAB
- NORETHINDRONE 0.5 MG per TAB
- NORETHINDRONE 1 MG per TAB